Interactions between trimpex(trimethoprim) and Cerebyx (fosphenytoin)
trimethoprim and fosphenytoin (Moderate Drug-Drug)
MANAGEMENT: Monitoring for clinical and laboratory evidence of hydantoin toxicity is recommended. Dose adjustments may be necessary. Patients should be advised to notify their physician if they experience symptoms of hydantoin toxicity (e.g., drowsiness, visual disturbances, change in mental status, seizures, nausea, or ataxia).






